Scarica l'app Stockscreener
13.02
0.70%
0.09
Dopo l'orario di chiusura:
13.02
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$12.93
Aprire:
$13.02
Volume 24 ore:
4.06M
Relative Volume:
0.72
Capitalizzazione di mercato:
$2.61B
Reddito:
$3.68B
Utile/perdita netta:
$-627.00M
Rapporto P/E:
-4.1364
EPS:
-3.1477
Flusso di cassa netto:
$104.00M
1 W Prestazione:
-3.27%
1M Prestazione:
+18.26%
6M Prestazione:
+1.96%
1 anno Prestazione:
-18.78%
Intervallo 1D:
$12.88
$13.27
Intervallo di 1 settimana:
$12.35
$14.04
Portata 52W:
$9.405
$16.29
Dentsply Sirona Inc Stock (XRAY) Company Profile
Nome
Dentsply Sirona Inc
Settore
Industria
Telefono
844-546-3722
Indirizzo
13320 BALLANTYNE CORPORATE PLACE, CHARLOTTE, NC
Compare XRAY vs ISRG, BDX, MDLN, ALC, RMD
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
XRAY
Dentsply Sirona Inc
|
13.02 | 2.59B | 3.68B | -627.00M | 104.00M | -3.1477 |
ISRG
Intuitive Surgical Inc
|
356.83 | 120.92B | 11.03B | 3.16B | 3.22B | 8.7251 |
BDX
Becton Dickinson Co
|
158.92 | 43.08B | 21.37B | 1.41B | 3.07B | 3.9437 |
MDLN
Medline Inc
|
39.70 | 32.77B | 29.14B | 1.07B | 1.05B | 1.1956 |
ALC
Alcon Inc
|
67.28 | 33.12B | 10.63B | 819.00M | 1.59B | 1.6577 |
RMD
Resmed Inc
|
203.08 | 28.33B | 5.54B | 1.52B | 1.74B | 10.37 |
Dentsply Sirona Inc Stock (XRAY) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-04-15 | Iniziato | Citigroup | Sell |
| 2026-02-19 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2025-12-09 | Iniziato | Barclays | Underweight |
| 2025-11-07 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2025-04-15 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2025-03-13 | Downgrade | Needham | Buy → Hold |
| 2025-02-14 | Iniziato | Wells Fargo | Equal Weight |
| 2025-01-23 | Downgrade | Jefferies | Buy → Hold |
| 2025-01-07 | Downgrade | Evercore ISI | Outperform → In-line |
| 2024-12-04 | Iniziato | Mizuho | Neutral |
| 2024-11-07 | Downgrade | Leerink Partners | Outperform → Market Perform |
| 2024-10-25 | Reiterato | Needham | Buy |
| 2024-08-20 | Reiterato | Needham | Buy |
| 2024-02-26 | Iniziato | Leerink Partners | Outperform |
| 2023-11-16 | Iniziato | Needham | Buy |
| 2023-11-10 | Aggiornamento | William Blair | Mkt Perform → Outperform |
| 2023-01-12 | Aggiornamento | William Blair | Underperform → Mkt Perform |
| 2022-08-05 | Downgrade | William Blair | Mkt Perform → Underperform |
| 2022-06-02 | Aggiornamento | UBS | Neutral → Buy |
| 2022-04-20 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2022-04-20 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2022-04-19 | Downgrade | BofA Securities | Buy → Neutral |
| 2022-04-19 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2022-01-31 | Iniziato | Morgan Stanley | Overweight |
| 2021-10-01 | Ripresa | Credit Suisse | Outperform |
| 2021-08-09 | Reiterato | H.C. Wainwright | Neutral |
| 2021-08-06 | Reiterato | Barrington Research | Outperform |
| 2021-08-05 | Ripresa | Credit Suisse | Outperform |
| 2021-03-02 | Aggiornamento | Barrington Research | Mkt Perform → Outperform |
| 2021-03-02 | Reiterato | H.C. Wainwright | Neutral |
| 2021-01-05 | Reiterato | H.C. Wainwright | Neutral |
| 2020-12-18 | Downgrade | Stifel | Buy → Hold |
| 2020-11-17 | Downgrade | Barclays | Equal Weight → Underweight |
| 2020-11-09 | Reiterato | H.C. Wainwright | Neutral |
| 2020-10-22 | Aggiornamento | Guggenheim | Neutral → Buy |
| 2020-08-10 | Reiterato | H.C. Wainwright | Neutral |
| 2020-06-16 | Iniziato | Piper Sandler | Overweight |
| 2020-06-15 | Reiterato | H.C. Wainwright | Neutral |
| 2020-05-27 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2020-05-11 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| 2020-04-24 | Reiterato | H.C. Wainwright | Neutral |
| 2020-04-08 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2020-04-07 | Downgrade | Goldman | Buy → Neutral |
| 2020-04-02 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
| 2020-03-03 | Reiterato | H.C. Wainwright | Neutral |
| 2020-02-19 | Reiterato | Stifel | Buy |
| 2019-12-11 | Downgrade | JP Morgan | Overweight → Neutral |
| 2019-08-02 | Aggiornamento | Wellington Shields | Hold → Gradually Accumulate |
| 2019-07-26 | Iniziato | Evercore ISI | In-line |
| 2019-07-09 | Reiterato | H.C. Wainwright | Neutral |
| 2019-05-30 | Iniziato | Wolfe Research | Peer Perform |
Mostra tutto
Dentsply Sirona Inc Borsa (XRAY) Ultime notizie
DENTSPLY SIRONA Inc (XRAY) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
DENTSPLY SIRONA Inc (XRAY) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
XRAY|DENTSPLY SIRONA Inc|Price:12.930|Chg%:+0.210 - TradingKey
3 Reasons to Sell XRAY and 1 Stock to Buy Instead - Yahoo Finance
Morgan Stanley Maintains Dentsply Sirona(XRAY.US) With Hold Rating - Moomoo
DENTSPLY SIRONA Inc|Price:12.930|Chg%:+0.210 - TradingKey
DENTSPLY SIRONA Inc. (XRAY) Stock forecasts - Yahoo Finance UK
Dentsply Sirona to review Q2 2026 results on August 6 - scanx.trade
Dentsply Sirona to Host Second Quarter Conference Call on August 6th - The Manila Times
DENTSPLY SIRONA Inc. (XRAY) discloses initial insider filing for CFO - Stock Titan
Dentsply Sirona Inc (XRAY) Shares Fall 4.2% -- What GF Score of 55 Tells Investors - GuruFocus
Dentsply Sirona, Smile Train mark 7,000 cleft surgeries, estimate US$470M impact - Oral Health Group
Dentsply Sirona stock trades steady as recent earnings and margin trends shape investor focus - AD HOC NEWS
DENTSPLY SIRONA (XRAY) Could Be 69% Undervalued On Its Dental Care Narrative - Sahm
Dentsply Sirona Inc (XRAY) Stock Up 5.5% and Still Undervalued -- GF Score: 51/100 - GuruFocus
BlackRock, Inc.'s Strategic Acquisition of Dentsply Sirona Inc. Shares - GuruFocus
Endo Forum 2026: Dentsply Sirona demonstrated the value of global collaboration in advancing endodontics - marketscreener.com
Did Dentsply Sirona Inc. Insiders Breach their Fiduciary Duties to Shareholders? - AOL.com
Is It Too Late to Buy Dentsply Sirona Inc (XRAY) After 3.0% Rall - GuruFocus
The Bull Case For DENTSPLY SIRONA (XRAY) Could Change Following Its Shift Into Russell 2000 Indices - simplywall.st
XRAY Initiated Coverage by BMO Capital -- Rating Set to Market P - GuruFocus
BMO Capital Initiates DENTSPLY SIRONA at Market Perform With $12 Price Target - marketscreener.com
Dental Implant Market to Reach US$14.42 Billion by 2034, Driven by Rising Demand for Restorative and Cosmetic Dentistry | The Insight Partners - GlobeNewswire Inc.
Dentsply Sirona (XRAY) Coverage Initiated by BMO Capital with Ma - GuruFocus
BlackRock (XRAY) holds 12.6% of DENTSPLY SIRONA common stock - Stock Titan
B of A Securities Upgrades DENTSPLY SIRONA (XRAY) - MSN
Dentsply Sirona focuses on digital dentistry as investors weigh long term growth - Ad-hoc-news.de
Dentsply Sirona: The Recovery Story Needs More Than A Stock Rebound - Seeking Alpha
Dentsply Sirona stock rating held at Neutral by Piper Sandler - Investing.com Nigeria
DENTSPLY SIRONA Inc. (XRAY)’s Shares Are Flat Since Cramer Commented On Them - Yahoo Finance
From the first dental MRI to orthodontic AI: Four FDA clearances reshaping dentistry - Oral Health Group
Rebecca Whitney assumes CEO role at Young Innovations - DrBicuspid.com
XRAYDENTSPLY Sirona Inc Options - Finviz
DENTSPLY SIRONA (XRAY) On 5 Million CEREC Restorations And The Undervalued Stock Narrative - Sahm
PDS Health Surpasses Five Million CEREC Chairside Restorations with Dentsply Sirona, Marking a Major Milestone in Scaled Digital Dentistry - Sahm
PDS Health and Dentsply Sirona Surpass 5 Million CEREC Chairside Restorations - Quiver Quantitative
PDS Health Surpasses Five Million CEREC Chairside - GlobeNewswire
Form 4 Dentsply Sirona Inc For: 1 July By Investing.com - Investing.com UK
[Form 4] DENTSPLY SIRONA Inc. Insider Trading Activity - Stock Titan
Guttacore Obturators Size #25Pack Of 30, Tulsa Dental / Dentsply (Free Shipping) - Santo André BIZ
Millions of same-day dental restorations: PDS Health hits 5M - Stock Titan
Does Dentsply Sirona’s (XRAY) Index Shift Recast Its Role in Dental Innovation Leadership? - simplywall.st
Seller dominance drives Dentsply Sirona stock down to $10.54 in weak session - Traders Union
DENTSPLY SIRONA : PDS Health Surpasses Five Million CEREC Chairside Restorations with Dentsply Sirona, Marking a Major Milestone in Scaled Digital Dentistry - marketscreener.com
Dentsply Sirona and HeyGears expand digital denture collaboration to one-piece production with Lucitone - Dental Tribune US
Precision Trading with Dentsply Sirona Inc. (XRAY) Risk Zones - Stock Traders Daily
DENTSPLY SIRONA Inc.(NasdaqGS: XRAY) dropped from Russell 1000 Index - marketscreener.com
DENTSPLY SIRONA Inc.(NasdaqGS: XRAY) added to Russell 2000 Index - marketscreener.com
DENTSPLY SIRONA Inc.(NasdaqGS:XRAY) dropped from Russell Midcap Value Benchmark - marketscreener.com
iCAT and BluePort Legal launch UPC battle against dental tech giant Dentsply - JUVE Patent
DENTSPLY SIRONA Inc.(NasdaqGS: XRAY) added to Russell 2000 Value Benchmark - marketscreener.com
Dentsply Sirona Inc Azioni (XRAY) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.62%
0.03%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):